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Abstract: Compounds that comprise the Erythrina alkaloid class of 
Natural products are based on a tetracyclic spironamine framework 
and exhibit a range of biological activities on the central nervous 
system. Herein we report a new and efficient total synthesis of this 
multiple ring system based on an intramolecular acylal cyclisation 
(IAC) approach. Using this methodology, the tetracyclic core was 
rapidly assembled over a two step domino process catalysed by a 
Lewis acid. The effect of heteroatoms, substituents and ring size on 
the IAC has also been investigated, and the broad application of this 
procedure is demonstrated by the synthesis of a library of derivatives 
in good yields with excellent regioselectivity. 
The Erythrina alkaloid family are a structurally diverse class of 
biologically active tetracyclic natural products that have been 
isolated from a number of tropical plant sources (Figure 1).[1] 
Many members of this calls of compound display a potent effect 
on the central nervous system (CNS) and as such, have been 
used in traditional medicine for their anxiolytic, anticonvulsant, 
sedative, antidepressive and antiepileptic effects.[2] The 
hydroalcoholic extract of Erythrina mulungu stem bark produces 
a non-opioid like analgesic effect,[3] whilst neuroethological and 
neurochemical experiments have demonstrated that extracts of 
the flowers of E. mulungu produce an anxiolytic effect.[4] Several 
studies have also reported that oral administration of extracts (3, 
10, 50, 100 and 200 mg/kg) produced anxiolytic effects in 
patients, which was analogous to the effects of diazepam.[5]  
All members of the Erythrina family possess a distinctive 
tetracyclic spironamine core and can be classified by variations 
of the D ring, into three sub-classes with aromatic, 
heteroaromatic or unsaturated lactone types as shown (Figure 
1).[6] As a result of their potent biological activity and challenging 
structural features, the synthesis of the Erythrina alkaloid core 
has attracted significant attention over a number of years via a 
variety of approaches, which have included radical and 
Pummerer mediated syntheses, intramolecular condensation 
and Diels-Alder reactions to name but a few.[6, 7]  
Nearly all methods focus on one of two routes to generate 
the three aliphatic rings, either via a single cyclisation, or via a 
simultaneous tandem cyclisation approach.[7-8] However, despite 
the reported potent biological activities, there has been a 
surprising lack reports on structural variation of the tetracyclic 
core. Herein, we not wish to report on our novel approach 
towards the Erythrina core and related structural derivatives.  
Figure 1. Classification of Erythrina alkaloids depending on D ring (aromatic, 
heteroaromatic and unsaturated lactone types) and on the number of oleofinic 
bonds (dienoid and alkenoid types). 
Following our recent reports on the reactivity and use of 
acylals, we reasoned that the Erythrina core could be obtained 
via a Lewis acid mediated intramolecular acylal cyclisation (IAC) 
to generate rings B and C in a two-step domino process 
triggered via acylal activation as outlined below (Scheme 1).  
Scheme 1. Cyclisation to generate the tetracyclic core 18. 
 
We envisaged that the cyclisation precursor could be 
obtained via condensation between a primary amine, 
cyclohexanone and diacetoxyacetyl chloride (Scheme 1). Under 
Lewis acid mediated IAC conditions, the enamine would cyclise 
onto the oxonium species 11 to generate the intermediate 
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imminium ion 12, which would react with the aromatic ring to 
form the tetracyclic Erythrina core 13. Simple variation of the 
ketone would therefore provide ready access to a range of 
analogues in this manner.[9] We decided to use BF3 as the Lewis 
acid in our cyclisations, due to its mild nature and our previous 
experience with its reactivity towards diacetoxyamides.[11-14]  
To investigate our hypothesis, we carried out initial 
condensation of cyclohexanone and 2-(3,4-
dimethoxyphenyl)ethanamine 14 under Dean and Stark water 
removal conditions.[10] The intermediate imine was reacted 
immediately with 2-chloro-2-oxoethane-1,1-diyl diacetate[11] 16 in 
the presence of pyridine to afford the key cyclisation precursor 
17a in 63% yield. Pleasingly, on reaction with BF3
.OEt2 (5 equiv.) 
and microwave heating of the reaction mixture at 65 ºC for 15 
minutes the tetracyclic core 18a was obtained in good yield 
(61%) and as a single diastereoisomer (Scheme 2). 
Scheme 2. Mechanism of cyclisation to generate the tetracyclic core 18a. 
 
Whilst it could be anticipated that out of the four potential 
diastereoisomers, one would be predominant, we were surprised 
by obtention of a single diastereoisomer in this instance. In order 
to understand this perhaps surprising selectivity, the relative 
configuration of the three contiguous chiral centres was 
determined via NMR J coupling and NOE measurements of the 
single diastereoisomer 18a. In combination with computational 
analysis of the four potential diastereoisomers,[15] the results 
from energy minimisation calculations and the values from the 
NMR parameters demonstrated that the hydrogen atoms at C2 
and C3 of the pyrrolidine ring would be configured in a trans 
relationship as this diastereoisoner is approximately 5.9 
Kcal/mol more stable than its closest related congener (see 
Supporting Information for full details of NMR and computational 
analysis). The results from the NOE studies confirmed these 
results where the two hydrogen atoms are trans to each other, 
with a large J coupling of 10.0 Hz (Figure 2).  
 
 
 
 
Figure 2. Determination of the relative configuration of the cyclised tetracyclic 
core structure 18a showing trans configuration around the pyrrolidinone ring. 
Following the success in the formation of the Erythrina 
core, we turned our attention towards formation of a range of 
closely related analogues via simple variation of the initial 
ketone component in order to explore the scope of the reaction 
via variation of ring size and incorporation of heteroatom 
substituents. The desired cyclisation precursors 17b-17j were 
prepared in good yields (17-67%) analogous to the formation of 
the Erythrina core as shown below (Scheme 3).  
 
 
 
Scheme 3. Formation of Erythrina cyclisation precursor analogues. 
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Compounds 17c and 17d were selected to explore the effect 
of ring size on diastereoselectivity, whilst the various heteroatom 
and substituted cyclohexyl rings were chosen to explore the 
scope of the reaction for the formation of potentially biologically 
active moieties. All compounds gave good yields of the 
cyclisation precursors, with the exception of the trifluoromethyl 
analogue 17j, which was a result of the volatility of the starting 
ketone. Having the cyclisation precursors in hand we focused on 
their cyclisation to generate Erythrina analogues, the results of 
which are shown below (Scheme 4).  
 
 
 
Scheme 4. Formation of Erythrina tetracyclic analogues. 
 
All reactions were heated in the microwave at 65 ºC for 15 
minutes as per the initial reaction with the cyclohexenyl 
cyclisation precursor 17a. Following purification, it can be readily 
observed that the cyclised products were obtained in good to 
excellent yield with good control over diastereoselectivity in most 
cases. Examination of the results for both the cyclopentyl 18c 
and cycloheptyl 18d Erythrina analogues demonstrated that the 
calculations of their respective minimised energies are an 
effective predictor of the outcome of the diastereoselectivity of 
cyclisation. In the case of the cyclopentyl analogue 18c, the 
trans diastereoisomer is 3.9 kcal/mol more stable than the 
corresponding cis diastereoisomer and as such, the ratio of 
trans/cis is 85/15. In the case of the cycloheptyl product 18d, the 
trans diastereoisomer is 0.4 kcal/mol more stable than the 
corresponding cis diastereoisomer and as such, the ratio 
deteriorates to give a trans/cis ratio of 60/40, clearly highlighting 
that the effect of reducing or increasing ring size leads to a 
lowering of diastereoselectivity. Incorporation of heteroatom six-
membered analogues of the Erythrina core was well tolerated 
with compounds 18b, 18g and 18h all obtained in good yields 
(30-61%) and as single diastereoisomers. Substitution of the 
cyclohexyl ring in the 4-position was also well tolerated with a 
phenyl group leading to a single diastereoisomer 18e in 
reasonable yield (40%), whilst the methyl substituted analogue 
18i and the trifluoromethyl analogue 18j giving reasonable yields 
of the cyclised products. In the case of 18j, the trifluoromethyl 
group led to a 70/30 mixture of diastereoisomers at the 
trifluoromethyl position. As per previous six-membered ring 
containing examples, the diastereoselectivity at the pyrrolodinyl 
ring was not affected. Pleasingly, we were also able to generate 
pentacyclic derivatives of the Erythrina core with compound 18f 
obtained as a single diastereoisomer in 48% yield and no 
evidence of any regioisomers.  
In summary, we have developed a novel two-step route to 
the Erythrina core which is based on an intramolecular acylal 
cyclisation (IAC) approach. In addition, we have shown that by 
simple variation of the starting ketone, that we can generate a 
range of substituted analogues with good stereocontrol. Our 
approach is readily adaptable to incorporation of heteroatom 
substituents and related pentacyclic derivatives. Further studies 
on variation of the D ring of the Erythrina core are under way in 
our laboratories and will be reported in due course.  
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